Phillip Marks
Impact in
- Urology top 5%
- Urological Disorders and Treatments
- Urinary Bladder and Prostate Research
-
- Hemoglobinopathies and Related Disorders
Papers in
- Co-authors
- Margit Fisch (12 shared papers)R A Rifkind (1 shared paper)Masao Tanaka (1 shared paper)A Bank (1 shared paper)Armin Soave (13 shared papers)Yoshiyuki Ohta (1 shared paper)O. J. Miller (1 shared paper)Michael Rink (15 shared papers)
- Journals
- World Journal of Urology (7 papers)British Journal of Urology (4 papers)Urologic Oncology Seminars and Original Investigations (2 papers)The Aging Male (2 papers)European Urology (2 papers)
- Partner nations
- GermanyAustriaUnited States
In The Last Decade
Phillip Marks
44 papers receiving 345 citations
Peers
Comparison fields: 5 of 62
- Urology 88
- Genetics 29
- Surgery 114
- Obstetrics and Gynecology 16
- Rheumatology 29
Countries citing papers authored by Phillip Marks
This map shows the geographic impact of Phillip Marks's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Phillip Marks with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Phillip Marks more than expected).
Fields of papers citing papers by Phillip Marks
This network shows the impact of papers produced by Phillip Marks. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Phillip Marks. The network helps show where Phillip Marks may publish in the future.
Co-authors
The 25 scholars most cited alongside Phillip Marks, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 47 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1976 | 106 | |
| 2 | 2016 | 54 | |
| 3 | 2020 | 17 | |
| 4 | 2022 | 16 | |
| 5 | 2019 | 12 | |
| 6 | Differentiating agents in cancer therapy. | 1991 | 12 |
| 7 | 2017 | 11 | |
| 8 | 2019 | 11 | |
| 9 | 2019 | 10 | |
| 10 | 2020 | 10 | |
| 11 | 2019 | 10 | |
| 12 | 2021 | 7 | |
| 13 | 2021 | 7 | |
| 14 | 2022 | 6 | |
| 15 | Clinical use of differentiating agents in cancer therapy. | 1990 | 6 |
| 16 | 2023 | 6 | |
| 17 | 2019 | 6 | |
| 18 | 2022 | 6 | |
| 19 | 2020 | 5 | |
| 20 | 2020 | 4 |
About Phillip Marks
Phillip Marks is a scholar working on Urology, Surgery, Pulmonary and Respiratory Medicine, Psychiatry and Mental health and Obstetrics and Gynecology, having authored 47 papers that have together received 372 indexed citations. Recurring topics across this work include Urological Disorders and Treatments (16 papers), Bladder and Urothelial Cancer Treatments (7 papers), Urinary Bladder and Prostate Research (6 papers), Renal cell carcinoma treatment (4 papers), Sexual function and dysfunction studies (4 papers), Ureteral procedures and complications (3 papers), Prostate Cancer Diagnosis and Treatment (3 papers) and Urinary and Genital Oncology Studies (3 papers). The work is most often cited by research in Urology (88 citations), Genetics (29 citations), Surgery (114 citations), Obstetrics and Gynecology (16 citations) and Rheumatology (29 citations). Phillip Marks has collaborated with scholars based in Germany, Austria and United States. Frequent co-authors include Margit Fisch, R A Rifkind, Masao Tanaka, A Bank, Armin Soave, Yoshiyuki Ohta, O. J. Miller, Michael Rink, M Terada and Roland Dahlem. Their work appears in journals such as World Journal of Urology, British Journal of Urology, Urologic Oncology Seminars and Original Investigations, The Aging Male and European Urology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.